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Abstract 
Problem: Opioid abuse may be a result of overprescribing opioids. There are no opioid 
prescribing recommendations for minor gynecologic surgery. As a result, there is a wide 
variation in prescribing practices at a privately-owned surgery center where excessive 
opioid prescription occurs.    
Methods: A quality improvement initiative with a descriptive, cohort design. A 
retrospective review of medical records and telephone surveys over three months resulted 
in the development of a series of posters describing prescription data for three 
procedures: hysteroscopy dilation and curettage (HDC), uterine ablation (UA), and 
laparoscopy (LAP). The trends and changes in opioid prescription practices were 
displayed throughout the surgery center every month. 
Results: A total on 526 medical records were reviewed (N=526) with HDC (n=358); UA 
(n=95); and LAP (n=73), and 45 telephone surveys were completed (N=45) with HDC 
(n=18); UA (n=9); and LAP (n=18). The number of patients receiving a prescription for 
opioids following HDC decreased from 23.3% to 16.4% (p = .001). When opioids were 
prescribed following HDC, UA, and LAP the mean milligrams of morphine equivalents 
(MMEs) prescribed decreased 34%, 19%, and 14%, respectively. Results were significant 
at the p < .05 level for all groups (HDC: p=.001; UA: p=.034; LAP: p= .039). 
Implications for practice: Opioid prescribing following monthly publications of 
prescribing practice and self-reported patient usage decreased the number of opioids 
prescribed.  Monitoring prescribing practices and regular patient surveys may assist in 
changing prescription practices and may be a reasonable option to decrease excessive 
opioid prescription at specialty surgery centers.  
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Decreasing Opioid Over-Prescription Following Outpatient Gynecologic Surgery 
 Opioid misuse and overdose continue to be a pervasive problem in the United 
States. In 2016, more than 11.5 million people reported misusing a prescription opioid 
(Centers for Disease Control [CDC], 2018) and there were more than 17,000 deaths 
involving a pharmaceutically manufactured opioid (Seth, Rudd, Noonan, & Haegerich, 
2018).  Moreover, most heroin users report first misusing prescription painkillers 
(Muhuri, Gfroerer, & Davies, 2013).  On October 26, 2017, the opioid crisis was declared 
a public health emergency by the U.S. Department of Health and Human Services (HHS) 
(HHS, 2017).  
 Opioids are an important modality for treating pain in the surgical patient, but are 
often overprescribed following surgery (Feinberg, Chesney, Srikandarajah, Acuna, & 
McLeod, 2017).  Excessive prescription can lead to abuse and diversion.  Opioid 
prescribing recommendations for common surgical procedures have been suggested by 
groups such as the Michigan Surgical Quality Collaborative (Michigan Surgical Quality 
Collaborative, 2018) and the Center for Opioid Research and Education (Center for 
Opioid Research and Education, 2018).  However, these recommendations are conflicting 
and do not include outpatient gynecologic procedures. 
 The aims of this project were to establish baseline data on opioid prescription and 
consumption; disseminate the data to surgeons and nurses; and decrease opioid over-
prescription following outpatient gynecology surgery.  This project was guided by the 
following study questions: 
For women undergoing outpatient gynecological procedures at a Midwest Multispecialty 
Surgery Center, aged 18 and older: 
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1. What percentage of patients received a prescription for an opioid at discharge 
from July 1st – September 30th following hysteroscopy dilation and curettage 
(HDC)? 
2. When opioids were prescribed, what was the median milligram of morphine 
equivalents (MME) prescribed from July 1st – September 30th for HDC, uterine 
ablation (UA), and laparoscopy (LAP), respectively? 
3. For those prescribed opioids, what was the self-reported MME consumed July 1st 
– September 30th? 
 Data from the three months prior to the intervention was compared with data from 
the three months following the intervention (February 1st – April 30th) for study questions 
1 and 2. Results were stratified by procedure type and answered the following study 
questions:  
With dissemination of information on opioid consumption was there: 
4. a decrease in the percentage of patients who received a prescription for opioids 
following HDC? 
5. a decrease in the mean MME prescribed, when opioids were prescribed, following 
HDC, UA, and LAP, respectively? 
Literature Review 
 A literature search was performed of MEDLINE, Cochrane, and CINAHL 
databases using Ebscohost.  The databases were searched using the terms: “opioid” and 
“postoperative”, not “chronic”, with truncation from August 31, 2013 to August 31, 
2018.   The database search identified 4,603 articles. After title review, 71 articles were 
selected for abstract review based on relevance to current prescribing trends after 
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outpatient surgery, historical perspective of the opioid crisis, and interventions to 
decrease inappropriate opioid prescription after surgery.  Nine study abstracts and two 
systematic review abstracts were initially found examining opioid medication use 
following discharge.  Two studies were excluded that included only pediatric 
populations, and another two were excluded that reported only on inpatient surgeries.  
One study was excluded because full text was not available through interlibrary loan. 
 The percentage of opioids used after surgery ranged from 5.6% to 58% of the 
total amount prescribed for adult populations (Feinberg, et. al., 2018; Bicket, Long, 
Provonost, Alexander, & Wu, 2017; Tan et al., 2018; Theils et al., 2018; Fujii et al., 
2018; Hill, McMahon, Stucke, & Barth, 2017).   All studies of adult patients reported 
patients were using significantly fewer opioids than prescribed.  However, one study of 
pediatric patients, included in the Feinberg et al. (2018) systematic review, found 
pediatric spinal fusion patients consumed 90.1% of the opioids prescribed.  
 All studies in the review included patients from more than one type of surgery and 
found that median opioid consumption varied by procedure.  Most studies reported doses 
of opioid prescription in MMEs (appendix A) (Feinberg, et. al., 2018; 2018; Fujii et al., 
2018; Tan et al., 2018; Thiels et al., 2018).  In general, people undergoing orthopedic 
surgery used a greater number of MMEs than those undergoing other types of surgeries 
(Hill et al., 2017; Thiels et al., 2018).  Only one study included median MME prescribed 
after hysteroscopy, but it did not include data on consumption for any gynecology 
procedures due to resource limitations (Fujii et al., 2018). 
 Consistently, less than 10% of patients surveyed reported disposing of excess pills 
in a manner approved of by the U.S. Food and Drug Administration (FDA) (Bicket et al, 
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2017; Hill et al., 2017; Thiels et al., 2018).  FDA-approved disposal methods include: 
returning the medication to a drug take-back location, mixing with an inedible substance 
and disposing of in the household trash, or, when other options are not available, flushing 
down the toilet (U.S. Food and Drug Administration, 2018).  
 Excess opioid prescription after surgery poses two risks: misuse and diversion.  
The risk of developing an opioid misuse disorder after surgery is low (0.2%), but the risk 
of developing new, persistent use is appreciable and is not significantly different between 
major and minor surgeries (5.9%-6.5%) (Brat et al., 2018; Brummett et al., 2017).  
Diversion is common, 40.8% of the 11.5 million adults in the U.S. who are misusing 
prescription opioids obtained the medication for free from friends or family, primarily by 
theft (Han et al., 2017).  Additionally, initiation of heroin use is 19 times more likely in 
people who have misused prescription pain medications (Muhuri, Gfroerer, & Davies, 
2013).  
 The opioid crisis has resulted from a complex interplay of social and political 
factors and has claimed more lives than the HIV epidemic of the 1980s (Theisen, Jacobs, 
Macleod, & Davies, 2018).  In 1990s, the American Pain Society proposed pain as the 
“fifth vital sign.”  Their aim was to make invisible suffering visible and provide a 
standardized pain rating scale (Baker, 2017).  Not long after, the Joint Commission, in 
conjunction with the National Pharmaceutical Council, released guidelines on assessing, 
reporting, and treating pain (National Pharmaceutical Council, 2001).  Five years later, 
the Centers for Medicare and Medicaid Services (CMS) implemented Hospital Consumer 
Assessment of Healthcare Providers and Systems (HCAHPS) surveys to assess healthcare 
experience from the patient’s perspective.  Three questions on the survey related to pain 
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management and control (CMS, 2018).  The next year, hospital reimbursement from 
CMS was related to HCAHPS scores (Theisen et al., 2018).  
 At the same time regulations were incentivizing pain treatment, pharmaceutical 
companies were aggressively marketing drugs like OxyContin directly to consumers 
(Haffajee & Mello, 2017).  From 1999 to 2015, the amount of opioid prescribed by 
physicians tripled (Guy et al., 2017).  Since 2004, Purdue Pharma, Cardinal Health, Insys 
Therapeutics, McKesson, and Mallincrodt have settled seven state/local lawsuits and four 
federal suits for misbranding, false-advertising, and kickbacks to prescribers (Haffajee & 
Mello, 2017).  Paradoxically, restrictions on scheduled medication prescribing may have 
contributed to overprescribing.  Until 2015, the only way to give a patient a prescription 
for an opioid in a Midwestern state was with a hand-written prescription.  Surgeons likely 
provided written prescriptions for opioids after surgery “just in case” since the logistics 
of obtaining a prescription after discharge would be difficult for both patient and 
provider.    
 Since the release of the CDC’s Opioid Prescribing Guidelines for Chronic Pain in 
2016, rate of high dose prescription (> 90 MMEs per day), concurrent benzodiazepine 
prescription, and overall rate of opioid prescription has fallen in the U.S. (Bohnert, Guy, 
& Losby, 2018).  However, the CDC guidelines do not address opioid prescribing after 
surgery.  Guidelines for surgical procedures have been proposed by groups such as the 
Michigan Surgical Quality Collaborative (Michigan Surgical Quality Collaborative, 
2018) and the Center for Opioid Research and Education (Center for Opioid Research 
and Education, 2018).  These guidelines made recommendations for common surgical 
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procedures, but do not include any gynecologic procedures commonly performed on an 
outpatient basis.  
 At the institutional level, several quality improvement initiatives have 
successfully resulted in decreased initial opioid prescription.  Hill, Stucke, Mcmahon, 
Beeman, and Barth (2018), presented institution-specific data gathered in a previous 
study on opioid prescription variability and over prescription following surgery to their 
surgeons during grand rounds.  In their educational intervention, they encouraged 
prescribers to recommend acetaminophen and NSAIDs first, and only use opioids for 
breakthrough pain.  After the intervention, opioid prescription fell 53%, and the number 
of refills requested by patients did not increase (Hill, Stucke, McMahon, Beeman, & 
Barth, 2018).  Another study found implementing evidence-based opioid prescription 
guidelines for one surgery had unintended effects on prescription practices following 
other types of surgeries, and decreased prescription in four other procedures without 
significantly increasing requests for refills (Howard, et al., 2018).  
 Chiu, Jean, Hoag, Freedman-Weiss, Healy, and Pei examined the effects of 
lowering the default number of opioid pills in the electronic medical record (EMR) when 
prescribing discharge analgesics (Chiu et al., 2018).  In this study, the autopopulated 
number of pills in the EMR was decreased from 30 to 12, forcing prescribers to manually 
enter a number greater than 12, if additional pills were required.  After the EMR change, 
the median number of opioid pills prescribed fell from 30 to 20, without a statistically 
significant change in refill requests (Chiu et al., 2018).  
 One theme emerged from the literature review regarding a lack of patient 
education on appropriate disposal of unused opioids.  Since pain tolerance varies from 
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person to person, it is impossible to predict the exact number of opioids required for each 
person.  Even if initial opioid prescription was decreased, some patients would still have 
excess pills.  A quality improvement initiative at Washington University in St. Louis 
sought to address this problem with a low cost, easily implementable intervention (Hasak, 
et al., 2017).  The intervention included dissemination of an opioid-disposal brochure to 
patient at the time surgery was scheduled and again at the time of discharge (Hasak et al., 
2017).  After the intervention, the number of patients who reported disposing of their 
unused medications appropriately doubled (Hasak et al., 2017). 
 This project used a Plan-Do-Study-Act framework for implementing change. This 
four-step cycle emphasizes continuous improvement of a product, process, or service.  
During the first step, plan, goals and success metrics are identified.  During the second 
step, do, the plan is implemented. During the third step, study, outcomes are measured 
and successes and failures are identified.  During the last step, act, the intervention is 
scaled-up or the goals and methods are adjusted and the cycle begins again (Deming 
Institute, 2018).  
Method 
Design 
 This quality improvement project utilized a descriptive cohort design for the 
survey portion and an uncontrolled before-and-after intervention study design for 
tracking prescribing changes. A retrospective medical record review of all eligible charts 
from July 1- September 30, 2018 was completed. Two attempts were made to contact all 
patients identified by the review as having met the inclusion criteria and having been 
prescribed opioids at discharge by phone. The results of the phone survey were used to 
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develop educational posters for prescribers. After the posters were displayed, another 
retrospective medical record review was completed to examine changes in prescribing 
patterns. The post-intervention data was collected from February 1- April 30, 2019.  
Setting 
 The setting for this project was a privately-owned ambulatory surgery center 
(ASC) in a Midwestern, suburban area.  The center was originally founded as a 
gynecology-only facility, and, despite expanding to include other specialties, maintains a 
large percentage of gynecology cases, approximately 1200 cases per year.  The facility is 
part of a larger network of ASCs and is not part of an academic medical center.  
Sample 
 A convenience sample of female patients from July 1, 2018 through September 
30, 2018, who were 18-years of age and older, who underwent HDC, UA, or LAP, and 
whose procedure was performed by an obstetrician/gynecologist at the surgery center.  
Exclusionary criteria included self-report of opioid use as a home medication on the 
admission record, other gynecological surgeries, or age less than 18-years.  For the 
survey phone call, convenience sampling was also used.  Two attempts were made to 
contact all patients identified in the chart review as having received an opioid 
prescription at discharge. Exclusionary criteria for the phone survey included: non-
English speaking or no working phone number listed in the chart.  
Procedures 
 A team was assembled including nurses, physicians, and the board of directors at 
the Midwestern surgical center. The proposal was first submitted for feedback on 
DECREASING OPIOID OVERPRESCRIPTION 
 
11 
 
feasibility and appropriateness to the board in September, 2018. Feedback was 
incorporated into the project proposal.  
 Prior to disseminating data, a medical record review and telephone survey 
compared opioid prescription with opioid consumption.  All patients logged received a 
random and unique identifier (1-1100) using randomizer.org. Since it was necessary to 
link patients who received an opioid to the information collected from their medical 
record, a hand-written key was created listing each participant’s identifier, name, and 
phone number.  The key was kept in a locked box within a locked cabinet in the medical 
records storage room.  Only the coordinator of the project had access to this box.  The 
key will be destroyed by shredding in 2022, per recommendation of the institutional 
review board (IRB). Data extracted from the medical record included: demographics data 
(age, race, date of surgery, procedure type, physician), type of opioid prescribed, dosage, 
and number of pills.  
 After the chart review was completed, up to three attempts were made to contact 
eligible participants (those that received an opioid and did not meet any exclusionary 
criteria) by phone. If contact was made, and patients verbally agreed to participate in the 
survey over the phone, three questions were asked and recorded.  Questions included: did 
they fill their prescription; how many pills were left over after their surgical pain 
resolved; and did they receive disposal instructions?  
 After all information was collected from the medical records and patient surveys, 
the amount of opioid prescribed and consumed was converted to MMEs.   For those 
prescribed opioids, the median number of MMEs prescribed was compared the median 
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number of MMEs consumed. All data collected was stored on a password-protected 
computer. 
 Once the data was collected and analyzed it was disseminated to OB/GYNs and 
nurses along with information on the consequences of over prescription through 
handouts, and via signage in the locker rooms and break room at the project site.  
Dissemination of information took place in January 2019, and continued throughout the 
duration of the study. Signage was updated monthly.  
 To determine if dissemination of this information resulted in any practice change, 
opioid prescribing was tracked for three months after the education was provided: 
February 1 through April 30, 2019. The following variables were compared pre- and 
post-intervention: 
1. Percentage of patients receiving opioid prescription following HDC 
2. MMEs prescribed, when opioids were prescribed, following HDC, UA, and LAP 
Data from the chart reviews was compared pre/post intervention using chi squared and t-
tests.  
Approval Process  
 This project was approved by the board of directors and compliance department at 
the project site on September 17, 2018, and by the University IRB in December, 2019.  
During the board meeting, one consideration of concern was that patients receiving the 
phone survey may believe their personal phone numbers had been “sold” to an outside 
company. To mitigate this risk, the person conducting the phone calls identified herself as 
an employee of the surgery center since this was a fact.  Another risk was the potential 
for breach of confidentiality.  To prevent this, all personal identifiers were removed from 
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the data collected. The projected benefits of this project were numerous and included: 
increased awareness of the consequences of over-prescription; development of 
gynecology specific recommendations for postoperative opioid prescription; a decrease in 
over prescription; and fewer unused pills resulting in less potential for misuse and 
diversion.  
Results 
A total of 526 medical records were reviewed (N=526). There were 203 patients 
identified for the pre-intervention HDC group. Ten medical records were not available 
leaving 193 medical records reviewed for the pre-intervention HDC cohort (n=193). 
There were 179 identified for the post-intervention HDC group. Eleven medical records 
were not available, and three patients were excluded for opioid use on admission, leaving 
165 medical records for the post-intervention HDC cohort (n=165). For those receiving a 
UA, 47 patients were initially identified for the pre-intervention group. One medical 
record was unavailable and one patient was excluded for opioid use on admission, 
resulting in 45 medical records for the pre-intervention UA cohort (n=45). For the 
postintervention group, 50 medical records were identified, and all met the inclusion 
criteria for the post-intervention UA cohort (n=50).  For LAP, 40 medical records were 
identified for the pre-intervention cohort (n=40) and 33 medical records were identified 
for the post-intervention LAP cohort (n=33). Finally, 45 patients consented to, and 
participated in the post-surgical telephone survey (N=45).  
There were no statistically significant differences between the pre-intervention 
cohorts and the post-intervention cohorts in race or age. Most patients were Caucasian 
(n= 475, 84.8% – 93.3%), followed by Black (n= 27, 0% - 7.3%), then Asian (n= 12, 0% 
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- 7.5%), and Hispanic (n=7, 0% - 4.4% (appendix B). All patients were female. The range 
of ages was 20 to 87 years. The mean age for HDC was 50.8 years (SD=11.4) and 49.2 
years (SD=11.4) in the pre- and post- intervention cohorts respectively.  For the UA 
cohort, the mean age for the pre-intervention cohort was 43.6 years (SD=6) and post-
intervention was 42.4 years (SD=5.7). Finally, the average age for the pre-intervention 
LAP cohort was 38.3 years (SD=10.3) and post-intervention was 37.4 years (SD=9.0) 
(appendix B). 
In the pre-intervention cohorts, there were no reports of unrelieved pain on 
postoperative day one for any patient who underwent HDC (n= 193) regardless of receipt 
of opioid prescription at discharge. Of the HDC patients, 45 received a prescription for 
opioids (23.3%). When opioids were prescribed, the median amount of MMEs prescribed 
was 75 (M=85.6; SD=47.1). Of those 45 patients, 18 (40%) consented to and completed 
the telephone survey. The median number of MMEs reported to be consumed by the 
surveyed group was zero. For those who underwent a UA, 36 (80%) patients received a 
prescription for opioids following the procedure. For those patients the median amount of 
MMEs prescribed was 112.5 (M=119.2; SD=53.4). Of the 36 patients, nine consented to 
and completed the telephone survey (25%). The median MMEs reported to be consumed 
by those surveyed was 60 (M=68.5; SD=60.4). Most patients (85%) who underwent a UA 
reported taking 100 MMEs or fewer. Finally, 38 (95%) patients received a prescription 
for opioids following LAP. For those patients, the median MMEs prescribed was 150 
(M=142.2; SD=49.3). Of those patients, 18 (47%) consented to the telephone survey. The 
median MMEs consumed by those surveyed was reported to be 33.7 (M=43.4; SD=42.7) 
(appendix C). Most patients (90%) took fewer than 90 MMEs following LAP.   
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Chi-squared analysis was used to compare the percentage of patients who 
received an opioid at discharge following HDC before and after the intervention and to 
compare patient report of uncontrolled pain on post-operative day one or two follow up 
call before and after the intervention. The percentage of patients who received an opioid 
at discharge following HDC decreased from 23.3% to 16.4% (p = .001). Most of the 
decreased prescription for HDC was seen in the final month of the chart review (appendix 
D). In fact, there was only one prescription for opioids following HDC in April. There 
was no statistically significant difference in patient report of uncontrolled pain on post-
operative day one or two follow-up call before and after the intervention (p = .2974) 
(appendix F). 
To compare the mean MME prescribed pre- and post-intervention, an unpaired-
samples t test was performed for each of the three procedures. The mean MME 
prescribed for HDC decreased 34% from 85.6 (SD=47.1) in the pre-intervention cohort to 
56.4 (SD=31.9) in the post-intervention cohort.  The difference between the two means 
was statistically significant at the .05 level (t=3.131, dƒ=68.8717, p=.001).  For the UA 
cohorts, the mean MME prescribed decreased 19% from 119.2 (SD=53.4) pre-
intervention to 96.6 (SD=43.6) post-intervention. The difference between the two means 
was statistically significant at the .05 level (t=2.008, dƒ=67.7.7202, p=.034).  Last, in the 
LAP cohort, the mean MME prescribed decreased 14% from 142.4 (SD=49.3) pre-
intervention to 121.7 (SD=46.4) post-intervention.  The difference between these two 
means was also statistically significant at the .05 level (t=1.746, dƒ=67.128, p=.039) 
(appendix E).  
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Discussion 
Providing monthly data to the outpatient surgical group appeared to be effective 
in changing prescribing opioid habits for HDC, UA, and LAP patients.  Based on the 
results of this study, the recommended number of MMEs to be prescribed following 
outpatient gynecologic surgery is: Zero for HDC procedures, 100 (or 13 Percocet, 5 mg 
equivalents) for UA procedures, and 90 (or 12 Percocet, 5 mg equivalents) for LAP 
procedures.  After posters of patient survey data were placed throughout the surgical 
center and distributed to physicians and nurses, the amount of opioids prescribed fell 
significantly for all three procedures. For HDC, the number of patients who received an 
opioid at discharge decreased 6.9% (p = .001). When opioids were prescribed after UA 
and LAP the mean MME prescribed decreased 19% and 14% (p=.034; LAP: p= .039), 
respectively.  Interestingly, the longer the posters were displayed, the greater decrease in 
opioid prescription. In fact, for HDC, there was no significant decrease in the percentage 
of patients who received a prescription until the third and final month of the study when 
only one patient received a prescription for opioids. The results of this project were 
consistent with opioid quality initiatives attempted at other institutions.  
One common apprehension voiced by prescribers was concern about the risk of 
under prescribing and uncontrolled pain. Despite the reductions in opioid prescriptions 
seen in this project, there was no increase in reports of uncontrolled pain or requests for 
additional medications. This is consistent with previous studies.  While pain, especially 
post-surgical pain is of concern, dispelling the myth that all post-surgical patients need an 
opioid is recommended. 
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Several practice guidelines for postsurgical opioid prescription have been released 
and revised in the last few years, however, these large-scale studies did not include 
specialty surgical procedures performed on an outpatient basis. A goal for future practice 
should include the development of practice guidelines for surgical specialty procedures, 
such as gynecological procedures, based on evidence. Often specialty procedures are 
performed in outpatient surgical centers not affiliated with academic hospitals, making 
research support difficult. Recommendations for further study include larger scale studies 
for specialty-specific surgeries and postoperative pain prescribing habits for minor to 
major procedures and in different types of surgical settings.  Further study is also needed 
in patient disposal of unused opioids since the overall aim is to decrease the number of 
opioids available for public consumption. 
Conclusion 
This outpatient women’s surgical center established an opioid prescription 
practice for postsurgical HDC, UA, and LAP pain control.  While postoperative surgical 
pain is of concern, there are procedures performed with little resulting pain.  Improved 
knowledge regarding the types of procedures not needing an opioid or needing only a few 
opioids may decrease the number of opioids prescribed.  Prescribing healthcare providers 
can play a vital role in decreasing the number of available opioids to the general public. 
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Appendix A 
Milligrams Morphine Equivalent (MME) Conversion Chart for Selected Opioids 
 
Type of Opioid (unit of 
measurement) 
MME Conversion Factor 
Codeine (mg) 0.15 
Hydrocodone (mg) 1 
Morphine (mg) 1 
Oxycodone (mg) 1.5 
Tramadol (mg) 0.1 
 
 
 
 
Reference 
 
Centers for Medicare and Medicaid Services. (2016). Opioid oral morphine milligram 
equivalent (MME) conversion factors. Retrieved from 
https://www.cms.gov/Medicare/Prescription-
DrugCoverage/PrescriptionDrugCovContra/Downloads/Opioid-Morphine-EQ-
Conversion-Factors-Aug-2017.pdf 
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Appendix B 
 
Table 1.  
Patient Characteristics Before and After Intervention 
  
 
Pre -Intervention 
 
 
Post-Intervention 
 
 
 
 
 
 
HDC 
(n=193) 
 
UA 
(n = 45) 
 
LAP 
(n = 40) 
 
HDC 
(n = 165) 
 
UA 
(n = 50) 
 
LAP 
(n = 33) 
Mean Age (SD) 50.8 
(11.4) 
43.6 (6.0) 38.3 (10.3) 49.2 (11.4) 42.4 (5.7) 37.4 (9.0) 
p value    .1864 .3202 .6954 
Race       
American 
Indian/ 
Alaska 
Native 
p value 
 
0; 0% 0; 0% 0; 0% 0; 0% 
1.0 
0; 0% 
1.0 
0; 0% 
1.0 
Asian 
p value 
 
 
2; 1.0% 0; 0% 3; 7.5% 6; 3.6% 
.0949 
0; 0% 
1.0 
1; 3.0% 
.4301 
Black or 
African 
American 
p value 
 
9; 4.7% 1; 2.2% 2; 5% 12; 7.3% 
.3543 
0; 0% 
.2943 
3; 9.1% 
.5025 
 
Hispanic 
or Latino 
p value 
 
 
2; 1.0% 2; 4.4% 0; 0% 3; 1.8% 
.5167 
0; 0% 
.1360 
0; 0% 
1.0 
Native 
Hawaiian 
or Pacific 
Islander 
p value 
 
 
0; 0% 0; 0% 0; 0% 0; 0% 
1.0 
0; 0% 
1.0 
0; 0% 
1.0 
White 
p value 
 
 
177; 
91.7% 
42; 93.3% 35; 87.5% 143; 86.7% 
.1261 
50 
.0643 
28; 84.8% 
.7403 
Not 
Recorded 
p value 
 
3; 1.6% 0; 0% 0; 0% 1; 0.6% 
.3748 
0; 0% 
1.0 
1; 3% 
.2734 
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Appendix C 
 
Table 2.  
Third Quarter 2018 Survey of Patients Prescribed Opioids  
 
 
 
 
 
 
HDC 
(n = 45) 
 
UA 
(n = 36) 
 
LAP 
(n = 38) 
Number of patients contacted 
n (%) 
 
18 (40%) 9 (25%) 18 (47%) 
Prescription vs Consumption    
 
Prescribed MME 
Mean (SD)  
Median  
 
 
85.6 (47.1) 
75 
 
 
119.2 (53.4) 
112.5 
 
 
142.4 (49.3) 
150 
 
Consumed MME 
Mean (SD) 
MME  
 
MMEs consumed 
by 85th percentile 
and below 
 
 
 
24.3 (54.3) 
0 
 
 
68.5 (60.4) 
60 
 
 
100  
 
 
43.4 (42.7) 
33.75 
 
 
90 
 
Note. Two surveyed patients in the UA group could not remember how many opioid pain 
pills were taken after discharge following their procedure.  
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Appendix D 
Table 3.1. 
Percentage of Patients Receiving an Opioid at Discharge Pre/Post-intervention 
Following HDC, by Month 
 
 
 
Preintervention 
n = 193 
Feb 
n = 54 
March 
n = 49 
April 
n = 62 
Postintervention 
Feb – March 
Combined 
N 
 
45 13 13 1 27 
% 
 
23.3 24.1 26.5 1.6 16.4 
p value  .6272 .6400 .0001  0.001 
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Appendix E 
 
Table 3.2 
Mean MME when Opioids were Prescribed, Pre/Post-intervention 
 
 
 
Preintervention 
 
Postintervention 
 
Decrease 
 
p value 
HDC     
n 
 
45 27   
mean 
 
85.6 56.4 29.2 .001  
standard 
deviation 
 
47.1 31.9   
UA     
n 
 
36 40   
mean 
 
119.2 96.6 22.6 .034  
standard 
deviation 
 
53.4 43.6   
LAP     
n 
 
38 32   
mean 
 
142.4 121.7 19.7 .039  
standard 
deviation 
 
49.3 46.4   
 
Note. The mean MME prescribed for HDC decreased from 85.6 (SD=47.1) in the pre-
intervention cohort to 56.4 (SD=31.9) in the post-intervention cohort.  The difference 
between the two means was statistically significant at the .05 level (t=3.131, dƒ=68.8717, 
p=.001).  For the UA cohorts, the mean MME prescribed decreased from 119.2 
(SD=53.4) pre-intervention to 96.6 (SD=43.6) post-intervention. The difference between 
the two means was statistically significant at the .05 level (t=2.008, dƒ=67.7.7202, 
p=.034).  Last, in the LAP cohort, the mean MME prescribed pre-intervention was 142.4 
(SD=49.3) and compared to the mean in the post-intervention cohort of 121.7 (SD=46.4).  
The difference between these two means was also statistically significant at the .05 level 
(t=1.746, dƒ=67.128, p=.039). 
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Appendix F 
 
Table 3.3. 
Pain Controlled on Postoperative Day One: All Patients 
 
 
 
Preintervention 
n = 278 
Postintervention 
n = 248 
No report of 
uncontrolled pain 
n 
% 
 
 
277 
99.6 
 
 
245 
98.8 
   
Reported 
uncontrolled Pain 
n 
% 
 
 
1 
0.4% 
 
3 
1.2% 
p value  .2974 
 
Note. No report of uncontrolled pain included all patients marked on the day one or two 
postoperative call as “pain unrelieved with medications.” Everyone else, including those 
who were not available by phone were included in the “No report of uncontrolled pain.”  
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Appendix G 
Figure 1.  
Number of Opioid Pain Pills Prescribed Before and After Intervention 
 
 
Figure 4. This is a chart of the MMEs converted into their Percocet 5mg equivalents 
using the “MME Equivalency Chart” provided by the Centers for Medicare and Medicaid 
Services. (2016). Opioid oral morphine milligram equivalent (MME) conversion factors. 
Retrieved from https://www.cms.gov/Medicare/Prescription-
DrugCoverage/PrescriptionDrugCovContra/Downloads/Opioid-Morphine-EQ-
Conversion-Factors- 
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